Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04616417 · ClinicalTrials.gov registry record · NA

Investigational Oocyte Cryopreservation for Medical and Non Medical Indications

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT04616417: Completed NA study, sponsored by University of Illinois at Chicago.

NCT04616417 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04616417, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

This is a prospective study to assess the long term benefits and outcomes of the existing oocyte cryopreservation methods for fertility preservation in women with a potential medical or non medical risk of loss of fertility

Primary Outcome

We will obtain a structured fertility focused quality of life questionnaire (FertiQol) and survey to assess one year after harvest the impact of the process. We will compare cancer patients to those patients undergoing oocyte cryopreservation for non-medical reasons. FertiQol is scored based on the standards of the assessment tool in a quantitative manner. Only 9 patients completed the this questionnaire. FertiQoL consists of 36 items that assess core (24 items) and treatment-related (10 items)

Interventions

  • PROCEDURE Investigational Oocyte Cryopreservation

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2015-05-08
Est. Completion 2023-03-20
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT04616417 record still lists

NCT04616417 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Investigational Oocyte Cryopreservation is the first listed.

NCT04616417 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04616417 about?

NCT04616417 is a clinical study titled "Investigational Oocyte Cryopreservation for Medical and Non Medical Indications". This is a prospective study to assess the long term benefits and outcomes of the existing oocyte cryopreservation methods for fertility preservation in women with a potential medical or non medical risk of loss of fertility

What is the current status of trial NCT04616417?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2015-05-08. Estimated completion is 2023-03-20.

What interventions are being tested in trial NCT04616417?

The interventions under investigation include: Investigational Oocyte Cryopreservation (PROCEDURE).

Who is sponsoring clinical trial NCT04616417?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04616417's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04616417, the US trial registry maintained by the National Library of Medicine. NCT04616417 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.